Acrospire Investment Management LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 90 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q2 2017$80,000
-19.2%
1,608
-11.2%
0.08%
-8.5%
Q1 2017$99,000
-47.3%
1,810
-46.4%
0.08%
+6.5%
Q4 2016$188,000
-7.8%
3,380
-24.1%
0.08%
-43.4%
Q3 2016$204,000
-1.9%
4,456
-14.6%
0.14%
-12.3%
Q2 2016$208,000
-30.9%
5,215
-39.7%
0.16%
-25.8%
Q1 2016$301,0008,6420.21%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q3 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 385,954$16,723,00010.02%
JW Asset Management, LLC 73,649$3,191,0003.40%
Elk Creek Partners, LLC 168,714$7,310,0000.43%
NORTHPOINTE CAPITAL LLC 80,710$3,497,0000.39%
Ativo Capital Management LLC 33,096$1,434,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 155,318$6,730,0000.26%
ISTHMUS PARTNERS, LLC 17,406$754,0000.20%
Matarin Capital Management, LLC 48,952$2,121,090,0000.16%
GLOBEFLEX CAPITAL L P 4,324$187,0000.05%
Summit Trail Advisors, LLC 6,797$295,0000.04%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders